Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

286.92
+2.650.93%
Pre-market: 287.300.3800+0.13%07:32 EDT
Volume:189.62K
Turnover:54.31M
Market Cap:5.72B
PE:29.55
High:290.33
Open:285.73
Low:281.69
Close:284.27
52wk High:326.63
52wk Low:161.82
Shares:19.94M
Float Shares:19.35M
Volume Ratio:1.09
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.91
PE(LYR):46.81

Loading ...

Ligand Pharmaceuticals - to Use Part of Proceeds for Convertible Note Hedge Transactions

THOMSON REUTERS
·
Jun 22

Ligand Pharmaceuticals (LGND) Is Up 7.6% After Institutions Snap Up the Float and Earnings Jump – Has The Bull Case Changed?

Simply Wall St.
·
Jun 20

Ligand Pharma director Stephen L. Sabba disposes of common shares worth $544,830

Reuters
·
Jun 18

Ligand Pharmaceuticals director Jason Haas reports sale of 6,461 common shares worth $1.65 million

Reuters
·
Jun 16

Pelthos Therapeutics director Todd C. Davis buys USD 999,994 of common stock

Reuters
·
Jun 16

Ligand Pharma director Jason Aryeh disposes of 5,000 common shares worth $1.25 million

Reuters
·
Jun 13

Ligand Pharma director John L. LaMattina disposes of 4,591 common shares worth $1.15 million

Reuters
·
Jun 13

Ligand to host investor day webcast for shareholders

Reuters
·
Jun 10

Ligand Pharmaceuticals stockholders approve restated 2002 stock incentive plan at annual meeting

Reuters
·
Jun 10

Is Ligand Pharmaceuticals (LGND) Still Undervalued After Its Strong Recent Share Price Momentum

Simply Wall St.
·
Jun 07

Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Tenaya Therapeutics (TNYA)

TIPRANKS
·
Jun 04

Ligand CLO, Secretary Andrew Reardon sells USD 1.11 million in common shares

Reuters
·
Jun 03

BofA Securities Adjusts Ligand Pharmaceuticals Price Target to $266 From $263

MT Newswires Live
·
May 28

Ligand Pharma (LGND) Receives a Buy from Bank of America Securities

TIPRANKS
·
May 28

Ligand Pharmaceuticals to join Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
May 28

Xoma downgraded to Hold from Buy at Benchmark

TIPRANKS
·
May 22

Ligand Pharmaceuticals Bets Big on Royalty Growth

TIPRANKS
·
May 20

Is It Too Late To Consider Ligand Pharmaceuticals (LGND) After Its 97% One-Year Surge?

Simply Wall St.
·
May 19

XOMA Royalty amends merger agreement with Ligand Pharmaceuticals

TIPRANKS
·
May 18

Ligand amends XOMA Royalty merger agreement to add new holding company entity

Reuters
·
May 18